A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19
Clinical trial NCT05164133 · COMPLETED
Trial details
- NCT number
- NCT05164133
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-10
- Primary completion
- 2024-03-27
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.